Merz Pharma GmbH & Co. KGaA v Allergan Inc. [2006] EWHC 2686 (Pat) (30 October 2006)
The patent was found invalid for added matter because the claims extended to the use of the neurotoxic component, which was not disclosed in the original application. The judge held that the skilled person would not derive the subject matter of the claims directly and unambiguously from the original application. The...
Source-derived case information.
- Citation
- [2006] EWHC 2686 (Pat)
- Parties
- Claimant: Merz Pharma GmbH & Co. KGaA; Defendant: Allergan, Inc.
- Jurisdiction
- England and Wales
- Judgment Date
- 30 October 2006
- Procedural Posture
- Patent Revocation Action / First Instance Judgment
- Outcome
- Patent revoked
- Legal Topics
- Patent Validity, Added Matter, Novelty, Obviousness, Insufficiency, Pharmaceutical Patents
Source-derived case record
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Merz Pharma GmbH & Co. KGaA
Claimant
Allergan, Inc.
Defendant
Procedural Posture
Patent Revocation Action / First Instance Judgment
Legal Issues
- 1 Whether the patent discloses added matter beyond the original application
- 2 Whether the patent lacks novelty over prior art and prior use
- 3 Whether the patent is obvious in light of common general knowledge and prior art
Ratio Decidendi
The patent was found invalid for added matter because the claims extended to the use of the neurotoxic component, which was not disclosed in the original application. The judge held that the skilled person would not derive the subject matter of the claims directly and unambiguously from the original application. The patent was also found invalid for lack of novelty and obviousness over the prior art and prior use. The specification was held insufficient as it did not enable the skilled person to perform the invention across the full scope of the claims.
Court Disposition
Patent revoked
Orders
- European Patent (UK) 1 366 770 is revoked.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment